INMB short interest
INmune Bio Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,657,727 |
|---|---|
| Change vs prior report | 406,622 (+18.1%) |
| Change over six months | -22.4% |
| Days to cover | 6.96 (sector: 3.78) |
| Average daily volume | 381,620 |
| Rank in Healthcare | #255 of 922 by days to cover |
INMB short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,657,727 | +18.1% | 6.96 | 381,620 |
| 2026-09-15 | 2,251,105 | +3.1% | 7.78 | 289,177 |
| 2026-08-31 | 2,183,845 | +3.9% | 6.26 | 349,100 |
| 2026-08-14 | 2,102,037 | -4.6% | 4.98 | 421,846 |
| 2026-07-31 | 2,203,321 | -7.6% | 6.64 | 331,625 |
| 2026-07-15 | 2,384,123 | -22.3% | 2.21 | 1,080,469 |
| 2026-06-30 | 3,068,023 | -16.4% | 1.62 | 1,898,458 |
| 2026-06-15 | 3,668,941 | -0.6% | 11.27 | 325,484 |
| 2026-05-29 | 3,689,456 | +1.3% | 14.38 | 256,560 |
| 2026-05-15 | 3,641,628 | +2.9% | 5.34 | 681,667 |
| 2026-04-30 | 3,540,274 | +5.1% | 17.79 | 198,990 |
| 2026-04-15 | 3,369,296 | -1.6% | 10.07 | 334,657 |
| 2026-03-31 | 3,425,591 | +5.2% | 6.99 | 490,194 |
| 2026-03-13 | 3,256,235 | -14.5% | 5.81 | 560,935 |
| 2026-02-27 | 3,806,985 | -4.0% | 7.65 | 497,821 |
| 2026-02-13 | 3,964,097 | -2.1% | 13.07 | 303,189 |
| 2026-01-30 | 4,047,425 | +3.9% | 13.06 | 309,925 |
| 2026-01-15 | 3,896,241 | +20.2% | 11.39 | 342,062 |
| 2025-12-31 | 3,241,827 | -5.2% | 8.74 | 370,882 |
| 2025-12-15 | 3,419,054 | +9.4% | 5.52 | 619,469 |
| 2025-11-28 | 3,126,363 | -9.4% | 7.71 | 405,430 |
| 2025-11-14 | 3,449,639 | +8.0% | 9.87 | 349,637 |
| 2025-10-31 | 3,192,896 | -8.2% | 9.62 | 331,852 |
| 2025-10-15 | 3,476,629 | +6.0% | 8.94 | 388,946 |
| 2025-09-30 | 3,279,355 | -1.4% | 6.62 | 495,502 |
import finzdata as yf
yf.Ticker("INMB").short_interest # every report since 2017
yf.Client().short_interest(["INMB"], start="2018-01-01")Healthcare short interest · INMB price history · Who owns INMB · All short interest